Relypsa Inc (RLYP)

[ciciagt]

(RLYP) Is Climbing On Phase 1 Study Results1/25/2016 4:52 PM ET
Relypsa Inc. (RLYP) announced Phase 1 results after the bell Monday which showed that there was no clinically meaningful reduction in absorption for nine of the 12 drugs being tested when Veltassa was administered at the same time. The study was evaluating potential drug-drug interactions between Veltassa for oral suspension and 12 drugs that had previously demonstrated binding in in vitro tests.
Relypsa traded in a range throughout Monday's session and closed up by 0.01 at $19.62. The stock is now up 0.92 on 858K shares after the bell.
by RTT Staff Writer
http://www.rttnews.com/2603661/relypsa-inc-rlyp-is-climbing-on-phase-1-study-results.aspx